BACKGROUND: Surprisingly little is known about the long-term course of obsessive-compulsive disorder (OCD). This prospective study presents 2-year course findings, as well as predictors of course, from the Brown Longitudinal Obsessive Compulsive Study, the first comprehensive prospective investigation of the observational course of OCD in a large clinical sample. METHOD: The sample included 214 treatment-seeking adults with DSM-IV OCD at intake who identified OCD as the most problematic disorder over their lifetime. Subjects were enrolled from 2001-2004. At annual interviews, data on weekly OCD symptom status were obtained using the Longitudinal Interval Follow-Up Evaluation. Probabilities of full remission and partial remission over the first 2 years of collected data and potential predictors of remission were examined. RESULTS: The probability of full remission from OCD was 0.06, and the probability of partial remission was 0.24. Of the 48 subjects whose OCD symptoms partially or fully remitted, only 1 relapsed within the first 2 years. Earlier age at onset of OCD, greater severity of symptoms at intake, older age at intake, and being male were associated with a decreased likelihood of remission. Insight, diagnostic comorbidity, and treatment were not found to be associated with the likelihood of achieving full or partial remission. CONCLUSIONS: Though one-quarter of the sample had periods of subclinical OCD symptoms during the prospective period, full remission was rare, consistent with the view of OCD as a chronic and persistent illness. Age at onset, OCD symptom severity, current age, and sex emerged as potent predictors of course. Copyright 2010 Physicians Postgraduate Press, Inc.
BACKGROUND: Surprisingly little is known about the long-term course of obsessive-compulsive disorder (OCD). This prospective study presents 2-year course findings, as well as predictors of course, from the Brown Longitudinal Obsessive Compulsive Study, the first comprehensive prospective investigation of the observational course of OCD in a large clinical sample. METHOD: The sample included 214 treatment-seeking adults with DSM-IV OCD at intake who identified OCD as the most problematic disorder over their lifetime. Subjects were enrolled from 2001-2004. At annual interviews, data on weekly OCD symptom status were obtained using the Longitudinal Interval Follow-Up Evaluation. Probabilities of full remission and partial remission over the first 2 years of collected data and potential predictors of remission were examined. RESULTS: The probability of full remission from OCD was 0.06, and the probability of partial remission was 0.24. Of the 48 subjects whose OCD symptoms partially or fully remitted, only 1 relapsed within the first 2 years. Earlier age at onset of OCD, greater severity of symptoms at intake, older age at intake, and being male were associated with a decreased likelihood of remission. Insight, diagnostic comorbidity, and treatment were not found to be associated with the likelihood of achieving full or partial remission. CONCLUSIONS: Though one-quarter of the sample had periods of subclinical OCD symptoms during the prospective period, full remission was rare, consistent with the view of OCD as a chronic and persistent illness. Age at onset, OCD symptom severity, current age, and sex emerged as potent predictors of course. Copyright 2010 Physicians Postgraduate Press, Inc.
Authors: J L Eisen; S A Rasmussen; K A Phillips; L H Price; J Davidson; R B Lydiard; P Ninan; T Piggott Journal: Compr Psychiatry Date: 2001 Nov-Dec Impact factor: 3.735
Authors: Anthony Pinto; Benjamin D Greenberg; Marco A Grados; O Joseph Bienvenu; Jack F Samuels; Dennis L Murphy; Gregor Hasler; Robert L Stout; Scott L Rauch; Yin Y Shugart; David L Pauls; James A Knowles; Abby J Fyer; James T McCracken; John Piacentini; Ying Wang; Virginia L Willour; Bernadette Cullen; Kung-Yee Liang; Rudolf Hoehn-Saric; Mark A Riddle; Steven A Rasmussen; Gerald Nestadt Journal: Psychiatry Res Date: 2008-06-02 Impact factor: 3.222
Authors: Sarah L Garnaat; Christina L Boisseau; Agustin Yip; Nicholas J Sibrava; Benjamin D Greenberg; Maria C Mancebo; Nicole C R McLaughlin; Jane L Eisen; Steven A Rasmussen Journal: J Clin Psychiatry Date: 2015-12 Impact factor: 4.384
Authors: Nicholas J Sibrava; Christina L Boisseau; Maria C Mancebo; Jane L Eisen; Steven A Rasmussen Journal: Depress Anxiety Date: 2011-08-04 Impact factor: 6.505
Authors: Maria C Mancebo; Christina L Boisseau; Sarah L Garnaat; Jane L Eisen; Benjamin D Greenberg; Nicholas J Sibrava; Robert L Stout; Steven A Rasmussen Journal: Compr Psychiatry Date: 2014-04-24 Impact factor: 3.735
Authors: Samuel J House; Shanti P Tripathi; Bettina T Knight; Natalie Morris; D Jeffrey Newport; Zachary N Stowe Journal: Arch Womens Ment Health Date: 2015-07-16 Impact factor: 3.633
Authors: Kathleen D Askland; Sarah Garnaat; Nicholas J Sibrava; Christina L Boisseau; David Strong; Maria Mancebo; Benjamin Greenberg; Steve Rasmussen; Jane Eisen Journal: Int J Methods Psychiatr Res Date: 2015-05-21 Impact factor: 4.035
Authors: Brian L Odlaug; Eric Weinhandl; Maria C Mancebo; Erik L Mortensen; Jane L Eisen; Steven A Rasmussen; Liana R N Schreiber; Jon E Grant Journal: Ann Clin Psychiatry Date: 2014-02 Impact factor: 1.567
Authors: Caleb M Pardue; Nicholas J Sibrava; Christina L Boisseau; Maria C Mancebo; Jane L Eisen; Steven A Rasmussen Journal: J Obsessive Compuls Relat Disord Date: 2014-07-01 Impact factor: 1.677
Authors: Jon E Grant; Maria C Mancebo; Eric Weinhandl; Brian L Odlaug; Jane L Eisen; Steven A Rasmussen Journal: Int Clin Psychopharmacol Date: 2013-07 Impact factor: 1.659
Authors: Michael H Bloch; Christy Green; Stephen A Kichuk; Philip A Dombrowski; Suzanne Wasylink; Eileen Billingslea; Angeli Landeros-Weisenberger; Benjamin Kelmendi; Wayne K Goodman; James F Leckman; Vladimir Coric; Christopher Pittenger Journal: Depress Anxiety Date: 2013-03-26 Impact factor: 6.505